Endonasal endoscopic resection of juvenile nasopharyngeal angiofibroma
Keywords:
juvenile nasopharyngeal angiofibroma, intraoperative bleeding, surgery, recurrenceAbstract
Juvenile nasopharyngeal angiofibroma (JNA) is a benign, highly vascular; and locally invasive tumor: Because the location of these tumors makes conventional surgery difficult, interest in endoscopic resection is increasing, particularly for the treatm ent of lesions that do not ex tend laterally into the infratemporal fossa. We report the results ofour series of 23 patients with JNA (stage IlB or lower) who underwent transnasal endoscopic resection under hypoten sive general anesthesia with out preoperative embolization of the tumor. All tumors were successfully excised. The amount of intra operative blood loss was acceptable. We observed only 1 recurrence, which was diagnosed 19 months postoperatively in a patient with a stage IlB primary tumor: We observed only 3 complications during follow up all synechia. We conclude that endoscopic resection of JNAs is safe and effective. The low incidence of recurrence and complications in this series indicates that preoperative embolization may not be necessary for lesions that have not undergone extensive spread; instead, intraoperative bleeding can be adequately controlled with good hypotensive general anesthesia.
References
Fang R, Sun W, Shi J, Xu R, Peng L, Lai Y, et al. Risk Factors and Characteristics of the Recurrence of Juvenile Nasopharyngeal Angiofibroma: A 22-Year Experience With 123 Cases at a Tertiary Center. Clin Exp Otorhinolaryngol. 2022 Nov 30;15(4):364–71.
Baba A, Kurokawa R, Kurokawa M, Srinivasan A. MRI features of sinonasal tract angiofibroma/juvenile nasopharyngeal angiofibroma: Case series and systematic review. J Neuroimaging. 2023 Sep;33(5):675–87.
Szymańska A, Szymański M, Czekajska-Chehab E, Szczerbo-Trojanowska M. Two types of lateral extension in juvenile nasopharyngeal angiofibroma: diagnostic and therapeutic management. Eur Arch Otorhinolaryngol. 2015 Jan;272(1):159–66.
AbdelRahman Y. Ali, Hussam Elbosraty, Sameh Zamzam. Nasal Angiofibroma; Ten Years’ Experience of Odd Criteria. Egypt J Ear Nose Throat Allied Sci. 2021 Jan 1;22(22):1–6
Da Costa JB, Carcao A, Duarte D, Viana M. Juvenile Nasopharyngeal Angiofibroma: From Diagnosis to Surgical Approach. J Biomed Res Environ Sci. 2021 Jul 31;2(7):538–42.
Da Costa JB, Carcao A, Duarte D, Viana M. Juvenile Nasopharyngeal Angiofibroma: From Diagnosis to Surgical Approach. J Biomed Res Environ Sci. 2021 Jul 31;2(7):538–42.
Adham M, Hajarani K, Rachmadi L, Suroyo I. Bilateral juvenile nasopharyngeal angiofibroma: A rare case report. Acta Oto-Laryngol Case Rep. 2021 Dec 31;6(1):45–52.
Al-Ahmari MS, Assiri KS. Juvenile Nasopharyngeal Angiofibroma in a Woman: A rare case report. Egypt J Hosp Med. 2018 Jul 1;72(5):4572–5.
Alshaikh NA, Eleftheriadou A. Juvenile Nasopharyngeal Angiofibroma Staging: An Overview. Ear Nose Throat J. 2015 Jun;94(6):E12–22.
Saylam G, Yücel OT, Sungur A, Önerci M. Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol. 2006 Feb 1;70(2):227–34.
Mishra A, Sachadeva M, Jain A, Shukla NM, Pandey A. Human Papilloma virus in Juvenile Nasopharyngeal Angiofibroma: possible recent trend. Am J Otolaryngol. 2016 Jul 1;37(4):317–22.
Szyfter W, Balcerowiak A, Gawęcki W, Juszkat R, Wierzbicka M. Juvenile nasopharyngeal angiofibroma—20 years of experience in endoscopic treatment. Otolaryngol Pol. 2021 Feb 16;75(2):9–14.
Szyfter W, Balcerowiak A, Gawęcki W, Juszkat R, Wierzbicka M. Juvenile nasopharyngeal angiofibroma—20 years of experience in endoscopic treatment. Otolaryngol Pol. 2021 Feb 16;75(2):9–14.
Oliveira JAA, Tavares MG, Aguiar CV, de Azevedo JF, Sousa JRF, de Almeida PC, et al. Comparison between endoscopic and open surgery in 37 patients with nasopharyngeal angiofibroma. Braz J Otorhinolaryngol. 2012 Jan 1;78(1):75–80.
Diaz A, Wang E, Bujnowski D, Arimoto R, Armstrong M, Cyberski T, et al. Embolization in Juvenile Nasopharyngeal Angiofibroma Surgery: A Systematic Review and Meta‐Analysis. The Laryngoscope. 2023 Jul;133(7):1529–39.
López F, Triantafyllou A, Snyderman CH, Hunt JL, Suárez C, Lund VJ, et al. Nasal juvenile angiofibroma: Current perspectives with emphasis on management. Head Neck. 2017;39(5):1033–45.
Overdevest JB, Amans MR, Zaki P, Pletcher SD, El‐Sayed IH. Patterns of vascularization and surgical morbidity in juvenile nasopharyngeal angiofibroma: A case series, systematic review, and meta‐analysis. Head Neck. 2018 Feb;40(2):428–43.
Tiwari PK, Teron P, Saikia N, Saikia HP, Bhuyan UT, Das D. Juvenile Nasopharyngeal Angiofibroma: A Rise in Incidence. Indian J Otolaryngol Head Neck Surg Off Publ Assoc Otolaryngol India. 2016 Jun;68(2):141–8.
Glad H, Vainer B, Buchwald C, Petersen BL, Theilgaard SA, Bonvin P, et al. Juvenile nasopharyngeal angiofibromas in Denmark 1981–2003: diagnosis, incidence, and treatment. Acta Otolaryngol (Stockh). 2007 Jan;127(3):292–9.
Abdelwahab M, Overdevest JB, Elmokadem A, El‐sisi H, El‐Kholy NA, Zaki H, et al. Nasopharyngeal Angiofibroma Staging with a Novel Nominal Basis: An 18‐Year Study in a Tertiary Center. Otolaryngol Neck Surg. 2019 Aug;161(2):352–61.
Mishra A, Mishra SC. Changing trends in the incidence of juvenile nasopharyngeal angiofibroma: seven decades of experience at King George’s Medical University, Lucknow, India. J Laryngol Otol. 2016 Apr;130(4):363–8.
Vasani HH, Joshi CP, Patel KB. Trend analysis in management of juvenile nasopheryngeal angiofibroma: our institutional experience. Int J Otorhinolaryngol Head Neck Surg. 2019 Dec 23;6(1):94.
Handelsman DJ, Sikaris K, Ly LP. Estimating age-specific trends in circulating testosterone and sex hormone-binding globulin in males and females across the lifespan. Ann Clin Biochem. 2016 May;53(Pt 3):377–84.
Kothari DS, Linker LA, Tham T, Maroda AJ, McElfresh JM, Fastenberg JH, et al. Preoperative Embolization Techniques in the Treatment of Juvenile Nasopharyngeal Angiofibroma: A Systematic Review. Otolaryngol Neck Surg. 2023;169(3):454–66.
Liu Q, Xia Z, Hong R, Pan Y, Xue K, Liu Q, et al. Preoperative Embolization of Primary Juvenile Nasopharyngeal Angiofibroma: Is Embolization of Internal Carotid Artery Branches Necessary? Cardiovasc Intervent Radiol. 2023 Aug 1;46(8):1038–45.
Labra A, Chavolla-Magaña R, Lopez-Ugalde A, Alanis-Calderon J, Huerta-Delgado A. Flutamide as a Preoperative Treatment in Juvenile Angiofibroma (JA) with Intracranial Invasion: Report of 7 Cases. Otolaryngol Neck Surg. 2004;130(4):466–9.
Lim AE, Hurley R, Slim MAM, Melia L. A Narrative Review of Flutamide in Juvenile Nasopharyngeal Angiofibroma. Indian J Otolaryngol Head Neck Surg. 2023 Sep 1;75(3):2707–12.
Sitenga G, Granger P, Hepola K, Aird J, Silberstein PT. The use of flutamide for the neoadjuvant treatment of juvenile nasopharyngeal angiofibroma: a review of the literature comparing results by pubertal status and tumor stage. Int J Dermatol. 2022 Nov;61(11):1346–52.
Wendler O, Dlugaiczyk J, Birk S, Schick B. Anti-proliferative effect of glucocorticoids on mesenchymal cells in juvenile angiofibromas. Head Neck. 2012;34(11):1615–21.
Margolin J, Soni H, Pimpalwar S. Medical Therapy for Pediatric Vascular Anomalies. Semin Plast Surg. 2014 May 31;28(02):079–86.
